Essential medicines and health products


Thirty-seventh meeting of the Expert Committee on Drug Dependence

The Thirty-Seventh meeting of the Expert Committee on Drug Dependence (ECDD) was held in Geneva, Switzerland, 16 – 20 November 2015. At the meeting, the ECDD reviewed a number of substances with potential for dependence, abuse and harm to health, it makes recommendations to the UN Secretary-General, on the need for and level of international control of these substances. For more information, please do not hesitate to contact The Secretariat at: ecddsecretariat@who.int

37th ECDD Expert Committee member

Open session of the 37th ECDD

Interested parties were invited to make presentations to an open session of the 37th meeting of the Expert Committee on Drug Dependence.

Agenda and meeting documents

2. Procedural matters

2.1 Election of chairperson and rapporteur

2.2 Declaration of interests

2.3 Adoption of agenda

3. For information of the committee

3.1 Work of international bodies on controlled substances
3.1a Update from INCB

3.1b Update from UNODC

3.1c Update from WHO

3.2 Criteria for assessing new psychoactive substances

3.3 Terminology

4. Follow up of recommendations made by 36th ECDD

5. Reviews of psychoactive substances

5.1 MT-45
5.2 Acetylfentanyl
5.3 α-Pyrrolidinovalerophenone (α-PVP)
5.4 4-Fluoroamphetamine (4-FA)
5.5 para-Methyl-4-methylaminorex (4,4’-DMAR)
5.6 para-Methoxymethylamphetamine (PMMA)
5.7. Etizolam (INN)
5.8. Phenazepam
5.9 Methoxetamine (MXE)

6. Update

6.1 Ketamine (INN)
6.2 Cannabis and cannabis resin

7. Update on improving data collection and evidence base for substance evaluation; interagency collaboration

8. Future agenda items

9. Review and adoption of the ECDD meeting report

Closure of meeting